Schober Justine M, Dulabon Lori M, Woodhouse Christopher R
Hamot Medical Center, Urology, Erie, PA, USA.
BJU Int. 2004 Sep;94(4):616-9. doi: 10.1111/j.1464-410X.2004.05011.x.
To explore the symptoms, radiological findings and outcome after valve ablation in patients who present late with posterior urethral valves (PUV) and who typically have mild forms of the disease with often minimal upper tract changes; these patients frequently escape detection by ultrasonography in utero and the diagnosis may be delayed to as late as adolescence.
The charts of 70 boys (mean age 7.46 years, range 2-14) diagnosed late with PUV and treated with value ablation were retrospectively reviewed. Before ablation, history of voiding habits, voiding frequency, presence of enuresis, dysuria and the incidence of gross haematuria was recorded. Findings of a physical examination, laboratory testing (urine analysis and serum creatinine levels), ultrasonography and voiding cysto-urethrography (VCUG) were noted. After valve ablation, a review included a detailed voiding history and re-examination of abnormal variables including an assessment of enuresis, voiding frequency and ultrasonography. The mean (range) follow-up was 25 (1-78) months. One patient was lost after his first follow-up visit, but data were included to that time.
The most common presenting symptom was voiding dysfunction; 47 (67%) presented with nocturnal enuresis, 42 (60%) with urinary frequency and 12 (17%) with a history of urinary tract infection. On physical examination 12 (17%) had mild age-corrected hypertension. Microhaematuria was present in 21 (30%) but all patients had normal serum creatinine levels. Ultrasonography showed hydronephrosis in 33 (47%) and a postvoid residual volume in 57 (81%). On VCUG, 52 (79%) patients had clear evidence of PUV, 22 (31%) bladder trabeculation, 11 (16%) vesico-ureteric reflux and eight (11%) diverticula. On cystoscopy, 67 (96%) patients presented with the classic sail-shaped PUV and three a ring-shaped valve. After surgical ablation of the valve most patients dramatically improved; 31 of 42 (74%) had resolution of urinary frequency, 24 of 33 (73%) of diurnal enuresis and 17 of 47 (38%) nocturnal enuresis. Of 57 patients, 39 (68%) established good bladder emptying. Of 33 affected, 20 (60%) had some reduction of hydronephrosis but 63% continued to have some symptoms of voiding dysfunction.
PUV should be considered in boys presenting with voiding dysfunction. After valve ablation most patients improve dramatically. Despite surgery, enuresis, urinary frequency and poor bladder emptying persisted in some and required further treatment. The continued bladder dysfunction suggested that irreversible urinary tract damage may have occurred. Even in this apparently mildly affected group, long-term follow-up is essential.
探讨后尿道瓣膜症(PUV)患者出现较晚且通常病情较轻、上尿路改变往往极小的情况下,瓣膜消融后的症状、影像学表现及预后;这些患者常在子宫内超声检查时漏诊,诊断可能延迟至青春期。
回顾性分析70例诊断较晚且接受瓣膜消融治疗的PUV男孩(平均年龄7.46岁,范围2 - 14岁)的病历。消融前,记录排尿习惯史、排尿频率、遗尿、排尿困难及肉眼血尿的发生率。记录体格检查、实验室检查(尿液分析和血清肌酐水平)、超声检查及排尿性膀胱尿道造影(VCUG)的结果。瓣膜消融后,复查包括详细的排尿史及对异常变量的重新检查,包括对遗尿、排尿频率及超声检查的评估。平均(范围)随访时间为25(1 - 78)个月。1例患者在首次随访后失访,但该时间点的数据仍被纳入。
最常见的首发症状是排尿功能障碍;47例(67%)有夜间遗尿,42例(60%)有尿频,12例(17%)有尿路感染史。体格检查时,12例(17%)有轻度年龄校正后的高血压。21例(30%)有镜下血尿,但所有患者血清肌酐水平均正常。超声检查显示33例(47%)有肾积水,57例(81%)有残余尿量。在VCUG检查中,52例(79%)患者有明确的PUV证据,22例(31%)有膀胱小梁形成,11例(16%)有膀胱输尿管反流,8例(11%)有憩室。膀胱镜检查时,67例(96%)患者呈现典型的帆状PUV,3例为环状瓣膜。瓣膜手术消融后,大多数患者显著改善;42例中有31例(74%)尿频症状消失,33例中有24例(73%)日间遗尿消失,47例中有17例(38%)夜间遗尿消失。57例患者中,39例(68%)膀胱排空良好。33例有肾积水的患者中,20例(60%)肾积水有所减轻,但63%的患者仍有一些排尿功能障碍症状。
对于出现排尿功能障碍的男孩应考虑PUV。瓣膜消融后大多数患者显著改善。尽管进行了手术,部分患者仍存在遗尿、尿频及膀胱排空不良,需要进一步治疗。持续的膀胱功能障碍提示可能已发生不可逆的尿路损害。即使在这个看似病情较轻的群体中,长期随访也至关重要。